Automated description from the Alliance of Genome Resources (Release 3.1)
Predicted to have nicotinate transmembrane transporter activity. Involved in negative regulation of fatty acid metabolic process. Predicted to localize to Golgi apparatus; apical plasma membrane; and endoplasmic reticulum. Is expressed in several structures, including alimentary system; genitourinary system; nervous system; respiratory system; and sensory organ. Orthologous to human SLC22A13 (solute carrier family 22 member 13).